凝固市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00030085
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 250
Buy Now

【研究报告】凝血市场预计将从2022年的62.9528亿美元增长到2030年的108.5328亿美元;预计 2022 年至 2030 年复合年增长率为 7.0%。
市场洞察和分析师观点:
随着血液凝固和其他导致血液相关疾病的病例不断增加,凝血市场规模正在扩大凝块。 Medsafe 新西兰药品和医疗器械安全局估计,每年每 10,000 名服用口服避孕药的女性中就有 2-6 人面临凝血问题。抗凝药物,也称为血液稀释剂,主要用于预防和治疗血栓。在医院期间服用血液稀释剂很常见,尤其是在诊断后的前 5-10 天,此时病情被认为是最严重或最急性的。然而,那些具有适当风险状况的人最初可能会被开出血液稀释剂在家使用。此外,由于心脏动脉血液凝固引起的心血管疾病病例的增加也推动了凝血市场的增长。
生长驱动因素和挑战:
根据国家罕见疾病组织的数据,A 型血友病是常见的 X 连锁隐性遗传性疾病之一,也是继冯·维勒布兰德病之后第二常见的遗传性凝血因子缺乏症。此外,在美国,每 5,000 名男婴儿中就有 1 人患有 A 型血友病。根据 2020 年全球血友病护理研究,随着时间的推移,全球已发现并记录了 393,658 例出血性疾病病例,其中包括 241,535 例血友病病例、87,729 例血管性血友病病例和 64,394 例其他出血性疾病病例。根据美国国家医学图书馆 (NLM) 的数据,2020 年美国约有 30,000-33,000 名男性受到血友病影响。
根据美国癌症协会 (CLL) 的报告,美国记录了约 21,250 例新发血友病病例。慢性淋巴细胞白血病将于 2021 年出现。美国疾病控制与预防中心 (CDC) 2020 年 2 月的更新指出,美国受深静脉血栓影响的人数可能达到 900,000 人(每 1,000 人中有 1-2 人)。同一消息来源估计,在美国,每年有 60,000-100,000 名美国人死于静脉血栓栓塞。据美国卫生与公众服务部称,2020 年约有 10 万美国人被诊断患有镰状细胞病 (SCD),这是最常见的遗传性血液疾病之一。此外,到 2050 年,患有 SCD 的人数预计将增长约 30%。
根据国家医学图书馆的数据,2020 年,欧盟有 8000 万人患有血液疾病。国家罕见疾病组织表示,到 2022 年,免疫性血小板减少症 (ITP)(一种自身免疫性出血性疾病)每年影响美国每 100 万人中约有 66 名成年人。因此,血液疾病患病率的上升推动了凝血市场的增长。
与传统凝血分析仪相比,即时护理 (POC) 凝血分析仪具有显着的优势。然而,POC 分析仪的成本高于可负担的实验室测试。根据加拿大健康药物和技术局 (CADTH) 的数据,罗氏 CoaguChek 的平均成本为 500 美元至 2,000 美元,而 PT-INR 检测的成本为 4 美元至 4 美元31. 这些成本可与电池和维护的额外成本相结合,导致 POC 凝血分析仪的年度总成本更高。因此,这些测试分析仪的高成本限制了它们在新兴市场的采用和增长。
将凝血分析仪部署到临床环境中并向患者提供会对医疗保健提供者提供的服务产生重大的财务影响。西门子 Healthineers 提供了一款落地式凝血分析仪,售价 25 万美元。凝血分析仪的年度服务维护成本约为 2,000 美元至 3,000 美元。此外,制造凝血分析仪的公司需要遵守政府组织制定的一些严格的规则和法规才能获得商业发布的批准,这进一步增加了这些设备的总体价格。因此,与凝血分析仪相关的高成本限制了凝血市场的增长。
战略见解
报告细分和范围:
凝血市场根据疾病适应症、类型、产品、技术、终端进行划分用户和地理位置。根据疾病适应症,凝血市场分为维生素 K 缺乏症、肝病、弥散性血管内凝血和肺栓塞、循环抗凝剂的发展、血友病、冯维勒布兰德氏病等。根据类型,凝血市场分为临床实验室分析仪和即时检测分析仪。临床实验室分析仪进一步分类为对照品和校准品、测定和试剂、仪器/系统、凝血因子等。根据提供的产品,凝血市场分为诊断和治疗。诊断环节又分为凝血酶原时间检测、纤维蛋白原检测、活化凝血时间检测、活化部分凝血活酶时间检测、D-二聚体检测、血小板功能检测等。治疗领域进一步分为抗纤溶药物、避孕药、去氨加压素和免疫抑制药物、维生素K补充剂、血液稀释剂、凝血酶抑制剂或溶栓剂、替代疗法、导管辅助血栓清除等。根据技术,凝血市场分为光学技术、机械技术、电化学技术等。凝血市场按最终用户划分为临床实验室、医院等。根据地理位置,凝血市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度) 、韩国、澳大利亚和亚太其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
细分分析:
根据产品提供,凝血市场分为诊断和治疗。诊断环节又分为凝血酶原时间检测、纤维蛋白原检测、活化凝血时间检测、活化部分凝血活酶时间检测、D-二聚体检测、血小板功能检测等。治疗领域进一步分为抗纤溶药物、避孕药、去氨加压素和免疫抑制药物、维生素K补充剂、血液稀释剂、凝血酶抑制剂或溶栓剂、替代疗法、导管辅助血栓清除等。 2022年,诊断领域在凝血市场中占据更大份额。预计治疗领域在 2022 年至 2030 年期间将实现更高的复合年增长率。凝血功能在凝血障碍的诊断和监测服用影响凝血过程的药物的患者方面发挥着重要作用。纤维蛋白原测试评估纤维蛋白原蛋白(一种凝血因子)的水平。当身体组织或血管受损时,凝血因子结合形成血块并止血。纤维蛋白原测试用于跟踪出现出血过多或静脉或动脉异常阻塞等症状的个体。
活化凝血时间 (ACT) 测试主要用于跟踪高剂量普通肝素治疗。 ACT 通常用于在需要预防凝血的医疗或外科手术(例如心脏搭桥手术、冠状动脉成形术和透析)之前、期间和之后的短时间内监测高剂量肝素治疗。这是一种快速测试,可以在手术或其他医疗程序之前在患者床边进行。它还可以在手术期间或手术后立即在手术室中或手术室附近定期进行。
血小板聚集和促进凝血的能力是通过使用专用设备的各种称为血小板功能测试的测定来测量的。除了评估人们是否出血过多之外,血小板功能测试还可用于其他目的。进行这些测试是为了降低血小板的聚集能力,特别是对于更有可能经历心脏病或有害血栓的人。这些患者可能会服用减少血小板活化或其聚集能力的药物。可以对服用这些抗血小板药物(例如低剂量阿司匹林或氯吡格雷)的患者进行血小板功能测试,以跟踪其治疗效果。
可以使用 D-二聚体测试排除血栓。 D-二聚体测试用于诊断深静脉血栓 (DVT)、中风和肺栓塞 (PE)。建议将 D-二聚体测试作为附加测试。由于 D-二聚体是一种敏感但特异性较差的测试,因此它只能用于排除 DVT 而不是确认诊断。
凝血市场,按产品划分 – 2022 年和 2030 年

区域分析:< br>根据地理位置,凝血市场分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。北美是凝血市场增长的最大贡献者。预计 2022 年至 2030 年,亚太地区的凝血市场复合年增长率最高。由于血液疾病发病率不断上升、心房颤动 (AFib) 等心血管疾病的发生率不断增加,以及主要市场参与者从事新产品和现有产品开发,北美占据了重要的凝血市场份额。此外,政府对预防血液疾病的支持预计将在预测期内推动北美凝血市场的增长。美国在北美凝血市场占有最大份额。根据美国疾病控制与预防中心 (CDC) 的数据,2019 年美国约有 183,321 份死亡证明中提到了 AFib 的死亡原因,并且是其中近 26,535 例病例的主要原因。此外,预计到 2030 年,美国将有 1,210 万人患有 AFib。CDC 数据还提到,美国每 5,000 名男新生儿中就有 1 人患有 A 型血友病;此外,每年约有 400 名婴儿出生时患有 A 型血友病。它还提到,2012 年至 2018 年期间,美国约有 33,000 名男性被诊断患有血友病。此外,该国近300万人患有贫血症。美国有数百万人携带可导致镰状细胞性贫血和血友病等血液疾病的基因。据美国卫生与公众服务部称,镰状细胞病(一种血液疾病)影响着该国超过 100,000 人。消息人士还提到,冯·维勒布兰德病 (VWD) 是美国女性最常见的遗传性血液疾病之一。因此,心血管疾病和血液疾病发病率的增加可能会促进美国凝血市场的增长。
行业发展和未来机遇:
下面列出了凝血市场主要参与者的各种举措:< br>2021年8月,西门子医疗推出Sysmex CN-3000和CN-6000止血系统。这些全自动系统使诊断人员能够在实验室中有效地执行中量和大量凝血测试。 2020 年 7 月,Sysmex 在日本和 EMEA 推出 CN-6500 和 CN-3500 自动化凝血分析仪。这些集成分析仪融合了其前身 CN-6000/CN-3000 的功能,例如高水平的生产率、可靠性、可操作性和可维护性。它们由使用化学发光酶免疫分析方法 (CLEIA) 的测量单元组成,这是一种由自动免疫分析系统开发的测量原理。 CN-6500 和 CN-3500 分析仪可以灵活测量,响应血栓和止血领域的各种测试订单,包括使用单个设备进行凝血的分子标记。竞争格局和主要公司:
NORDIC BIOMARKER 是凝血市场上的一些知名参与者; ImproGen Diagnostik Kimya San。 &抽动。有限公司;诊断斯塔戈公司;西门子医疗保健私人有限公司、希森美康;海伦娜生物科学公司; F.霍夫曼-拉罗氏有限公司;根瑞生物科技有限公司;泛亚生物医药;和堀场医疗。这些公司专注于新产品发布和地域扩张,以满足全球不断增长的消费者需求,并增加其专业产品组合的产品范围。他们的全球业务使他们能够为大量客户提供服务,从而促进市场扩张。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is coagulation?

Coagulation or clotting is the process by which blood turns from a liquid into a gel and forms a blood clot. This potentially leads to hemostasis, which is the interruption of blood loss from a damaged vessel, followed by repair. Coagulation analyzer measures and evaluates the rate of clot formation or clot coagulation. It helps prevent the risk of heart attacks, embolism, and thrombosis by identifying the blood clots in the blood vessels. Obesity, heart attack, diabetes, and high blood pressure are diseases caused by lifestyle changes. Therefore, this device is a primary diagnostic tool for conditions like these. The demand for such devices in hospitals is increasing since it is a powerful automated device that serves as diagnostic tool for blood-related diseases.

Which segment is dominating the coagulation market?

The coagulation market is analyzed on the basis of disease indication, type, offering, technology, and end user. Based on disease indications, the coagulation market is segmented into vitamin K deficiency, liver disease, disseminated intravascular coagulation & pulmonary embolism, development of circulating anticoagulants, hemophilia, von Willebrand disease, and others. The liver disease segment held the largest share of the coagulation market in 2022. Further, the hemophilia segment is anticipated to register the highest CAGR from 2022 to 2030.

Who are the major players in market the coagulation market?

The coagulation market majorly consists of the players such NORDIC BIOMARKER; ImproGen Diagnostik Kimya San. & Tic. Ltd.; Diagnostica Stago, Inc.; Siemens Healthcare Private Limited; Sysmex; Helena Biosciences; F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Transasia Bio-Medicals; HORIBA Medical among others.

What are the driving and restraining factors for the coagulation market?

The factors such as the growing prevalence of blood disorders and rising incidence of cardiovascular diseases are the key driving factors behind the market development. However, the high costs associated with coagulation analyzers is hampering the market growth.

The List of Companies - Coagulation Market

  1. NORDIC BIOMARKER
  2. ImproGen Diagnostik Kimya San. & Tic. Ltd.
  3. Diagnostica Stago, Inc.
  4. Siemens Healthcare Private Limited
  5. Sysmex
  6. Helena Biosciences
  7. F. Hoffmann-La Roche Ltd
  8. Genrui Biotech Co., Ltd.
  9. Transasia Bio-Medicals
  10. HORIBA Medical

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports